Related Articles
Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance
Potential of a sphingosine 1‑phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
Sphingosine kinases are involved in the regulation of all‑trans retinoic acid sensitivity of K562 chronic myeloid leukemia cells
SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway